Ideal Living Skin Equivalents, From Old Technologies and Models to Advanced Ones: The Prospects for an Integrated Approach.


Journal

BioMed research international
ISSN: 2314-6141
Titre abrégé: Biomed Res Int
Pays: United States
ID NLM: 101600173

Informations de publication

Date de publication:
2024
Historique:
received: 09 10 2023
revised: 18 04 2024
accepted: 20 07 2024
medline: 26 8 2024
pubmed: 26 8 2024
entrez: 26 8 2024
Statut: epublish

Résumé

The development of technologies for the generation and transplantation of living skin equivalents (LSEs) is a significant area of translational medicine. Such functional equivalents can be used to model and study the morphogenesis of the skin and its derivatives, to test drugs, and to improve the healing of chronic wounds, burns, and other skin injuries. The evolution of LSEs over the past 50 years has demonstrated the leap in technology and quality and the shift from classical full-thickness LSEs to principled new models, including modification of classical models and skin organoids with skin derived from human-induced pluripotent stem cells (iPSCs) (hiPSCs). Modern methods and approaches make it possible to create LSEs that successfully mimic native skin, including derivatives such as hair follicles (HFs), sebaceous and sweat glands, blood vessels, melanocytes, and nerve cells. New technologies such as 3D and 4D bioprinting, microfluidic systems, and genetic modification enable achievement of new goals, cost reductions, and the scaled-up production of LSEs.

Identifiants

pubmed: 39184355
doi: 10.1155/2024/9947692
pmc: PMC11343635
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

9947692

Informations de copyright

Copyright © 2024 Andrei Riabinin et al.

Déclaration de conflit d'intérêts

The authors declare no conflicts of interest.

Auteurs

Andrei Riabinin (A)

Department of Cell Biology Koltzov Institute of Developmental Biology of the Russian Academy of Sciences, Moscow, Russia.

Maria Pankratova (M)

Department of Cell Biology Koltzov Institute of Developmental Biology of the Russian Academy of Sciences, Moscow, Russia.

Olga Rogovaya (O)

Department of Cell Biology Koltzov Institute of Developmental Biology of the Russian Academy of Sciences, Moscow, Russia.

Ekaterina Vorotelyak (E)

Department of Cell Biology Koltzov Institute of Developmental Biology of the Russian Academy of Sciences, Moscow, Russia.

Vasiliy Terskikh (V)

Department of Cell Biology Koltzov Institute of Developmental Biology of the Russian Academy of Sciences, Moscow, Russia.

Andrey Vasiliev (A)

Department of Cell Biology Koltzov Institute of Developmental Biology of the Russian Academy of Sciences, Moscow, Russia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH